Drugs Made In America Acquisition Corp. (DMAA)

NASDAQ: DMAA · Real-Time Price · USD

10.34

+0.01 (0.10%)

At close: Dec 5, 2025, 4:00 PM EST

10.37

+0.03 (0.29%)

After-hours: Dec 5, 2025, 5:31 PM EST

DMAA Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	0	0
Cash & Short-Term Investments	0	0
Prepaid Expenses	0.03	0
Total Current Assets	0.03	0
Long-Term Deferred Charges	-	0.55
Total Assets	237.63	0.55
Accrued Expenses	-	0.08
Short-Term Debt	-	0.66
Other Current Liabilities	0.15	0.06
Total Current Liabilities	0.46	0.8
Total Liabilities	244.96	0.8
Common Stock	0	0
Additional Paid-In Capital	-	0.03
Retained Earnings	-6.72	-0.28
Shareholders' Equity	-7.33	-0.24
Total Liabilities & Equity	237.63	0.55
Total Debt	-	0.66
Net Cash (Debt)	0	-0.66
Net Cash Per Share	0.00	-0.08
Filing Date Shares Outstanding	33.52	33.52
Total Common Shares Outstanding	33.52	8.57
Working Capital	-0.43	-0.79
Book Value Per Share	-0.22	-0.03
Tangible Book Value	-7.33	-0.24
Tangible Book Value Per Share	-0.22	-0.03

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q